Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 15 | 2023 | 972 | 3.540 |
Why?
|
| Sleep Apnea, Obstructive | 8 | 2023 | 256 | 3.100 |
Why?
|
| Hypertension | 8 | 2024 | 1584 | 2.820 |
Why?
|
| Circadian Rhythm | 11 | 2016 | 330 | 2.160 |
Why?
|
| Myocytes, Cardiac | 11 | 2011 | 697 | 1.770 |
Why?
|
| Dysbiosis | 5 | 2023 | 150 | 1.660 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2023 | 87 | 1.260 |
Why?
|
| Circadian Clocks | 3 | 2016 | 63 | 1.220 |
Why?
|
| Probiotics | 2 | 2023 | 241 | 1.190 |
Why?
|
| Blood Pressure | 7 | 2024 | 1555 | 1.040 |
Why?
|
| Stroke | 4 | 2022 | 1061 | 1.000 |
Why?
|
| Fecal Microbiota Transplantation | 4 | 2020 | 168 | 0.980 |
Why?
|
| Endothelin-1 | 2 | 2014 | 61 | 0.920 |
Why?
|
| Myocardium | 7 | 2011 | 1180 | 0.860 |
Why?
|
| Rats | 16 | 2023 | 6397 | 0.850 |
Why?
|
| Cerebrovascular Circulation | 2 | 2014 | 509 | 0.720 |
Why?
|
| Metabolome | 2 | 2021 | 355 | 0.710 |
Why?
|
| Fasting | 2 | 2021 | 334 | 0.710 |
Why?
|
| Period Circadian Proteins | 3 | 2016 | 42 | 0.690 |
Why?
|
| Hypotension | 1 | 2021 | 225 | 0.650 |
Why?
|
| Prebiotics | 1 | 2018 | 34 | 0.620 |
Why?
|
| Acetates | 1 | 2018 | 118 | 0.610 |
Why?
|
| Rats, Inbred WKY | 5 | 2022 | 110 | 0.600 |
Why?
|
| Rats, Inbred SHR | 5 | 2022 | 112 | 0.600 |
Why?
|
| Sleep | 4 | 2015 | 444 | 0.590 |
Why?
|
| Microbiota | 1 | 2024 | 545 | 0.590 |
Why?
|
| Animals | 33 | 2023 | 61362 | 0.530 |
Why?
|
| Aging | 7 | 2022 | 1531 | 0.530 |
Why?
|
| Fatty Acids | 4 | 2009 | 437 | 0.510 |
Why?
|
| Cerebral Arteries | 1 | 2016 | 100 | 0.500 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 25 | 0.490 |
Why?
|
| Gene Expression Regulation | 9 | 2011 | 4102 | 0.450 |
Why?
|
| Peroxynitrous Acid | 1 | 2013 | 8 | 0.450 |
Why?
|
| Rats, Long-Evans | 4 | 2018 | 110 | 0.440 |
Why?
|
| Biological Clocks | 2 | 2010 | 39 | 0.420 |
Why?
|
| Heart | 4 | 2009 | 1173 | 0.420 |
Why?
|
| Microcirculation | 1 | 2013 | 189 | 0.410 |
Why?
|
| Myocardial Contraction | 3 | 2010 | 289 | 0.400 |
Why?
|
| Reperfusion Injury | 1 | 2013 | 143 | 0.400 |
Why?
|
| CLOCK Proteins | 2 | 2011 | 33 | 0.390 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2009 | 160 | 0.370 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2011 | 809 | 0.370 |
Why?
|
| Disease Models, Animal | 8 | 2023 | 7323 | 0.370 |
Why?
|
| Fatty Acids, Volatile | 2 | 2020 | 51 | 0.360 |
Why?
|
| Brain Ischemia | 1 | 2013 | 311 | 0.350 |
Why?
|
| Cardiomegaly | 1 | 2011 | 168 | 0.350 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 153 | 0.320 |
Why?
|
| Muscle Proteins | 2 | 2011 | 486 | 0.320 |
Why?
|
| Glycoproteins | 1 | 2011 | 775 | 0.300 |
Why?
|
| Oleic Acid | 1 | 2007 | 20 | 0.290 |
Why?
|
| Brain | 2 | 2020 | 4199 | 0.280 |
Why?
|
| Rats, Wistar | 6 | 2008 | 598 | 0.270 |
Why?
|
| Vasoconstriction | 2 | 2019 | 117 | 0.270 |
Why?
|
| Palmitoyl-CoA Hydrolase | 1 | 2006 | 1 | 0.270 |
Why?
|
| Coenzyme A Ligases | 1 | 2006 | 14 | 0.260 |
Why?
|
| Cytosol | 1 | 2006 | 270 | 0.250 |
Why?
|
| ARNTL Transcription Factors | 3 | 2011 | 51 | 0.250 |
Why?
|
| Periodicity | 1 | 2005 | 71 | 0.250 |
Why?
|
| Signal Transduction | 3 | 2014 | 12036 | 0.240 |
Why?
|
| Germ-Free Life | 2 | 2021 | 66 | 0.230 |
Why?
|
| Interleukin-17 | 2 | 2023 | 251 | 0.230 |
Why?
|
| Vasodilation | 2 | 2016 | 212 | 0.220 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 690 | 0.210 |
Why?
|
| Tryptophan | 1 | 2022 | 143 | 0.200 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 1155 | 0.190 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 601 | 0.190 |
Why?
|
| Cholic Acid | 1 | 2021 | 17 | 0.190 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2021 | 104 | 0.190 |
Why?
|
| Cecum | 1 | 2021 | 35 | 0.190 |
Why?
|
| Mice | 12 | 2023 | 35420 | 0.180 |
Why?
|
| Time Factors | 6 | 2021 | 12979 | 0.180 |
Why?
|
| Oleanolic Acid | 1 | 2021 | 111 | 0.180 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2020 | 43 | 0.180 |
Why?
|
| Insulin | 1 | 2006 | 1424 | 0.170 |
Why?
|
| Feces | 3 | 2020 | 852 | 0.170 |
Why?
|
| Histamine | 1 | 2020 | 58 | 0.170 |
Why?
|
| Inflammation | 2 | 2020 | 2491 | 0.160 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 251 | 0.160 |
Why?
|
| Male | 19 | 2023 | 128520 | 0.160 |
Why?
|
| Random Allocation | 1 | 2021 | 728 | 0.160 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 367 | 0.160 |
Why?
|
| Intestines | 2 | 2020 | 727 | 0.160 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2019 | 33 | 0.160 |
Why?
|
| Bile Acids and Salts | 1 | 2021 | 270 | 0.160 |
Why?
|
| Mast Cells | 1 | 2020 | 224 | 0.160 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2019 | 179 | 0.150 |
Why?
|
| Immune System | 1 | 2019 | 275 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 485 | 0.140 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 2219 | 0.140 |
Why?
|
| Systole | 1 | 2016 | 217 | 0.140 |
Why?
|
| Biodiversity | 1 | 2016 | 95 | 0.140 |
Why?
|
| Recovery of Function | 2 | 2010 | 686 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 327 | 0.130 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2015 | 11 | 0.130 |
Why?
|
| Triglycerides | 2 | 2009 | 610 | 0.130 |
Why?
|
| Cerebrovascular Disorders | 1 | 2016 | 154 | 0.120 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 520 | 0.120 |
Why?
|
| Energy Metabolism | 2 | 2011 | 985 | 0.120 |
Why?
|
| Polysomnography | 1 | 2015 | 175 | 0.120 |
Why?
|
| Cognition | 1 | 2020 | 969 | 0.120 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 727 | 0.120 |
Why?
|
| Phylogeny | 1 | 2016 | 854 | 0.110 |
Why?
|
| Purinergic P2Y Receptor Agonists | 1 | 2013 | 5 | 0.110 |
Why?
|
| White Matter | 1 | 2015 | 191 | 0.110 |
Why?
|
| Perfusion | 3 | 2009 | 281 | 0.100 |
Why?
|
| Middle Cerebral Artery | 1 | 2013 | 113 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 231 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 1503 | 0.100 |
Why?
|
| Glycosylation | 1 | 2011 | 229 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2019 | 5658 | 0.090 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 580 | 0.090 |
Why?
|
| Isoproterenol | 1 | 2011 | 131 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1195 | 0.090 |
Why?
|
| Body Temperature | 1 | 2011 | 163 | 0.090 |
Why?
|
| Glucose | 2 | 2007 | 1213 | 0.090 |
Why?
|
| Phosphoserine | 1 | 2009 | 108 | 0.090 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2009 | 62 | 0.080 |
Why?
|
| Cardiotonic Agents | 1 | 2011 | 153 | 0.080 |
Why?
|
| Heart Rate | 2 | 2010 | 744 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 158 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 863 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2011 | 5692 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2014 | 3567 | 0.080 |
Why?
|
| Wakefulness | 1 | 2009 | 156 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 650 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 7054 | 0.080 |
Why?
|
| Humans | 7 | 2024 | 270804 | 0.080 |
Why?
|
| Age Factors | 3 | 2020 | 5443 | 0.070 |
Why?
|
| Glycogenolysis | 1 | 2007 | 10 | 0.070 |
Why?
|
| Regeneration | 1 | 2010 | 284 | 0.070 |
Why?
|
| Motor Activity | 1 | 2011 | 710 | 0.070 |
Why?
|
| In Vitro Techniques | 2 | 2007 | 1695 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 3582 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2007 | 418 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2006 | 60 | 0.060 |
Why?
|
| Uncoupling Protein 3 | 1 | 2005 | 8 | 0.060 |
Why?
|
| Sympathomimetics | 1 | 2005 | 17 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2007 | 312 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 697 | 0.060 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2005 | 21 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2007 | 625 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 4993 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2893 | 0.060 |
Why?
|
| Norepinephrine | 1 | 2005 | 285 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2006 | 212 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2006 | 340 | 0.060 |
Why?
|
| Ion Channels | 1 | 2005 | 235 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 4198 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 7647 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2009 | 5415 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2006 | 644 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2009 | 3328 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2005 | 377 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2009 | 4905 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2005 | 889 | 0.050 |
Why?
|
| RNA | 1 | 2006 | 1057 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 617 | 0.050 |
Why?
|
| Bifidobacterium longum | 1 | 2020 | 3 | 0.050 |
Why?
|
| Clostridium symbiosum | 1 | 2020 | 3 | 0.050 |
Why?
|
| Faecalibacterium prausnitzii | 1 | 2020 | 4 | 0.040 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2020 | 11 | 0.040 |
Why?
|
| Mucin-4 | 1 | 2020 | 17 | 0.040 |
Why?
|
| Mucin-2 | 1 | 2020 | 56 | 0.040 |
Why?
|
| Cytokines | 2 | 2020 | 2804 | 0.040 |
Why?
|
| Ileum | 1 | 2021 | 173 | 0.040 |
Why?
|
| Environment | 1 | 2021 | 170 | 0.040 |
Why?
|
| Risk Factors | 1 | 2017 | 17867 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2020 | 165 | 0.040 |
Why?
|
| Research Design | 1 | 2007 | 1562 | 0.040 |
Why?
|
| Gene Expression | 1 | 2007 | 3606 | 0.040 |
Why?
|
| Models, Biological | 1 | 2008 | 3187 | 0.040 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2019 | 41 | 0.040 |
Why?
|
| Phenylephrine | 1 | 2019 | 51 | 0.040 |
Why?
|
| Leukocytes | 1 | 2020 | 420 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2018 | 103 | 0.040 |
Why?
|
| Diet | 1 | 2006 | 1469 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 165 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2018 | 261 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2018 | 104 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 587 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2005 | 2084 | 0.030 |
Why?
|
| Memory | 1 | 2020 | 444 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 2112 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 509 | 0.030 |
Why?
|
| Bacteria | 1 | 2020 | 650 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 705 | 0.030 |
Why?
|
| Action Potentials | 1 | 2019 | 588 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 3435 | 0.030 |
Why?
|
| Nitric Oxide Donors | 1 | 2013 | 52 | 0.030 |
Why?
|
| Biological Factors | 1 | 2013 | 49 | 0.030 |
Why?
|
| Calcium | 1 | 2019 | 1571 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 277 | 0.020 |
Why?
|
| Trachea | 1 | 2013 | 301 | 0.020 |
Why?
|
| Mutation | 1 | 2011 | 15922 | 0.020 |
Why?
|
| Respiration | 1 | 2013 | 465 | 0.020 |
Why?
|
| Depression | 1 | 2020 | 1733 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2013 | 657 | 0.020 |
Why?
|
| Telemetry | 1 | 2007 | 39 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 1825 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2007 | 73 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2009 | 5146 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 353 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 5053 | 0.020 |
Why?
|
| Genome | 1 | 2008 | 689 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2007 | 1146 | 0.010 |
Why?
|
| Echocardiography | 1 | 2007 | 1218 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 2478 | 0.010 |
Why?
|
| Computational Biology | 1 | 2008 | 1295 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2007 | 1626 | 0.010 |
Why?
|
| DNA | 1 | 2007 | 3040 | 0.010 |
Why?
|